Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Alkene Reductase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117737014B reveals enzyme mutant for Compound I synthesis. Offers high purity and cost reduction in pharmaceutical intermediates manufacturing.